Details for Patent: 12,156,869
✉ Email this page to a colleague
Which drugs does patent 12,156,869 protect, and when does it expire?
Patent 12,156,869 protects ARBLI and is included in one NDA.
This patent has one patent family member in one country.
Summary for Patent: 12,156,869
| Title: | Losartan liquid formulations and methods of use |
| Abstract: | The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein. |
| Inventor(s): | Bhavya Teja KOLLA, Rahul Surana, Suketu Sanghvi, Jigar BHATT |
| Assignee: | Meds Merger Sub Ii LLC , Scienture LLC |
| Application Number: | US18/421,405 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent 12,156,869
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scienture | ARBLI | losartan potassium | SUSPENSION;ORAL | 218772-001 | Mar 13, 2025 | RX | Yes | Yes | 12,156,869 | ⤷ Start Trial | Y | A METHOD OF USING LOSARTAN FOR THE REDUCTION OF THE RISK OF STROKE IN PATIENTS WITH HYPERTENSION AND LEFT VENTRICULAR HYPERTROPHY | ⤷ Start Trial | |||
| Scienture | ARBLI | losartan potassium | SUSPENSION;ORAL | 218772-001 | Mar 13, 2025 | RX | Yes | Yes | 12,156,869 | ⤷ Start Trial | Y | A METHOD OF USING LOSARTAN FOR THE TREATMENT OF HYPERTENSION | ⤷ Start Trial | |||
| Scienture | ARBLI | losartan potassium | SUSPENSION;ORAL | 218772-001 | Mar 13, 2025 | RX | Yes | Yes | 12,156,869 | ⤷ Start Trial | Y | A METHOD OF USING LOSARTAN FOR THE TREATMENT OF DIABETIC NEPHROPATHY WITH AN ELEVATED SERUM CREATININE AND PROTEINURIA IN PATIENTS WITH TYPE 2 DIABETES AND A HISTORY OF HYPERTENSION | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,156,869
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 2022076746 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
